Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study

Abstract

Background Ischemic heart disease (IHD) is a leading cause of death worldwide. Also referred to as coronary artery disease (CAD) and atherosclerotic cardiovascular disease (ACD), it manifests clinically as myocardial infarction and ischemic cardiomyopathy. This study aims to evaluate the epidemiological trends of IHD globally. Methods The most up-to-date epidemiological data from the Global Burden of Disease (GBD) dataset were analyzed. GBD collates data from a large number of sources, including research studies, hospital registries, and government reports. This dataset includes annual figures from 1990 to 2017 for IHD in all countries and regions. We analyzed the incidence, prevalence, and disability-adjusted life years (DALY) for IHD. Forecasting for the next two decades was conducted using the Statistical Package for the Social Sciences (SPSS) Time Series Modeler (IBM Corp., Armonk, NY). Results Our study estimated that globally, IHD affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the world's population. Nine million deaths were caused by IHD globally. Men were more commonly affected than women, and incidence typically started in the fourth decade and increased with age. The global prevalence of IHD is rising. We estimated that the current prevalence rate of 1,655 per 100,000 population is expected to exceed 1,845 by the year 2030. Eastern European countries are sustaining the highest prevalence. Age-standardized rates, which remove the effect of population changes over time, have decreased in many regions.

Unlocking the Secrets of the Regenerating Fish Heart: Comparing Regenerative Models to Shed Light on Successful Regeneration

“…Since then, many life-saving treatments have been discovered [ 1 , 2 , 3 ] and myocardial infarction mortality rates have now fallen to 30% in the UK [ 4 ]. However, although there has been lots of progress, myocardial infarction still causes a global clinical burden [ 5 ]. During myocardial infarction, a coronary artery becomes blocked and approximately 1 billion cardiomyocytes die as they are starved of oxygen and nutrients [ 6 ].…”

Plasma Concentrations of Extracellular Vesicles Are Decreased in Patients with Post-Infarct Cardiac Remodelling

“…Coronary artery disease (CAD) is a major public health problem, affecting around 126 million individuals worldwide [ 1 ]. Improvements in the pharmacological and interventional treatment of CAD, including primary percutaneous interventions (PCI) for acute myocardial infarction (AMI), decreased the short-term mortality rate after AMI [ 2 , 3 ].…”

Micro‐RNA gene expressions during cardiopulmonary bypass

“…In particular, revascularization strategies are the most curative treatment methods. Surgical revascularization under cardiopulmonary bypass (CBP) by experienced teams for severe coronary artery disease patients is an effective and well‐understood method 1‐3 . Despite all advances, professionals are focusing on developing methods for understanding the quality of bypass, competence of myocardial perfusion, and longevity of the procedure.…”